Atlas Trials

Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Clinical trial NCT04777734 · AVAILABLE

Trial details

NCT number
NCT04777734
Sponsor
argenx
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CIDP

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.